Zepbound leads to more weight loss than Wegovy, Eli Lilly says
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...
Zepbound leads to more weight loss than Wegovy, new study finds
A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...
The American Journal of Managed Care9d
FDA Advised to Update Labels on GLP-1 Weight-Loss Drugs
In the US, liraglutide, semaglutide, and tirzepatide are currently under investigation for their ability to stimulate weight ...
Hosted on MSN8d
FDA Begins Review of Alnylam's sNDA for Expanded Amvuttra Use
Alnylam Pharmaceuticals ALNY announced that the FDA has accepted its supplemental new drug application (sNDA) seeking the ...
Pharmabiz5d
Lupin receives US FDA tentative approval for generic Janumet tablets
Lupin receives US FDA tentative approval for generic Janumet tablets: Our Bureau, Mumbai Friday, November 29, 2024, 11:15 Hrs [IST] Global pharma major Lupin Limited (Lupin) annou ...